The medtech industry is off to a fast start in 2025, with Zimmer Biomet making a major acquisition that is set to reshape its position in the foot and ankle devices market. This week, the orthopedic giant announced its decision to acquire Paragon 28 for $1.2 billion, marking a significant shift in Zimmer Biomet’s strategic focus. In this blog, we’ll break down how this deal strengthens Zimmer Biomet’s foothold in the foot and ankle space, examine the growing potential of the foot and ankle devices market, and explore the numbers highlighting why this market is becoming increasingly important for companies like Zimmer Biomet. A Strong Move in Foot and Ankle Devices Founded in 2010, Paragon 28 has positioned itself as a leader in the foot and ankle space, focusing on developing and commercializing surgical implants for various foot and ankle conditions. This includes addressing deformities, fractures, joint replacements, and trauma. Paragon 28’s business model is built around a portfolio...